Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study.
Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study.
复制标题
DOI:
10.1093/eurheartj/ehu263
复制
发表时间:
2015-04-21
影响因子:
39.3
通讯作者:
Douglas I
中科院分区:
文献类型:
--
作者:
Brauer R;Smeeth L;Anaya-Izquierdo K;Timmis A;Denaxas SC;Farrington CP;Whitaker H;Hemingway H;Douglas I
Antipsychotics increase the risk of stroke. Their effect on myocardial infarction remains uncertain because people prescribed and not prescribed antipsychotic drugs differ in their underlying vascular risk making between-person comparisons difficult to interpret. The aim of our study was to investigate this association using the self-controlled case series design that eliminates between-person confounding effects. All the patients with a first recorded myocardial infarction and prescription for an antipsychotic identified in the Clinical Practice Research Datalink linked to the Myocardial Ischaemia National Audit Project were selected for the self-controlled case series. The incidence ratio of myocardial infarction during risk periods following the initiation of antipsychotic use relative to unexposed periods was estimated within individuals. A classical case–control study was undertaken for comparative purposes comparing antipsychotic exposure among cases and matched controls. We identified 1546 exposed cases for the self-controlled case series and found evidence of an association during the first 30 days after the first prescription of an antipsychotic, for first-generation agents [incidence rate ratio (IRR) 2.82, 95% confidence interval (CI) 2.0–3.99] and second-generation agents (IRR: 2.5, 95% CI: 1.18–5.32). Similar results were found for the case–control study for new users of first- (OR: 3.19, 95% CI: 1.9–5.37) and second-generation agents (OR: 2.55, 95% CI: 0.93–7.01) within 30 days of their myocardial infarction. We found an increased risk of myocardial infarction in the period following the initiation of antipsychotics that was not attributable to differences between people prescribed and not prescribed antipsychotics.
登录
查看更多内容
影响因子:
1.9
作者:
Enger, C;Weatherby, L;Walker, AM
通讯作者:
Walker, AM
DOI:
10.1136/bmj.f2350
发表时间:
2013-05-20
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Herrett E;Shah AD;Boggon R;Denaxas S;Smeeth L;van Staa T;Timmis A;Hemingway H
通讯作者:
Hemingway H
DOI:
10.1056/nejmoa0806994
发表时间:
2009-01-15
期刊:
The New England journal of medicine
影响因子:
--
作者:
Ray WA;Chung CP;Murray KT;Hall K;Stein CM
通讯作者:
Stein CM
影响因子:
2.1
作者:
Farrington, C. Paddy;Whitaker, Heather J.;Hocine, Mounia N.
通讯作者:
Hocine, Mounia N.
影响因子:
--
作者:
Douglas, Ian J.;Smeeth, Liam
通讯作者:
Smeeth, Liam